KCM
BDSI

Kennedy Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Kennedy Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-292,683
Closed -$1.28M – 707
2020
Q2 		$1.28M Sell
292,683
-339,052
-54% -$1.52M 0.04% 556
2020
Q1 		$2.39M Buy
+631,735
New +$3.1M 0.09% 413
2015
Q4 		– Sell
-229,160
Closed -$1.27M – 788
2015
Q3 		$1.27M Sell
229,160
-840
-0.4% -$6.2K 0.03% 635
2015
Q2 		$1.83M Buy
230,000
+162,000
+238% +$1.39M 0.03% 603
2015
Q1 		$714K Buy
+68,000
New +$929K 0.01% 676
2014
Q2 		– Sell
-540,888
Closed -$4.57M – 808
2014
Q1 		$4.57M Buy
540,888
+96,784
+22% +$781K 0.09% 391
2013
Q4 		$2.62M Buy
444,104
+144,363
+48% +$744K 0.05% 500
2013
Q3 		$1.63M Buy
299,741
+74,237
+33% +$357K 0.03% 576
2013
Q2 		$916K Buy
+225,504
New +$1.06M 0.02% 652

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Kennedy Capital Management's BDSI Position: Q3 2020 in Review

Kennedy Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2020, closing a stake of 292,683 shares — an estimated $1.28M sold.

Kennedy Capital Management first reported a position in BDSI in Q2 2013 and held it in 9 quarters. The position peaked at $4.57M in Q1 2014. 147 funds tracked by Wall St. Rank hold BDSI as of Q3 2020.

  • Kennedy Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2020 after selling out during the quarter.
  • Kennedy Capital Management sold 292,683 BioDelivery Sciences International, Inc. shares in Q3 2020, an estimated $1.28M.
  • Kennedy Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 9 quarters.
  • Kennedy Capital Management's BioDelivery Sciences International, Inc. position peaked at $4.57M in Q1 2014.
  • 147 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2020.

Based on Kennedy Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.